As we have found that FTY720 treatment induces functional ERα reactivation and sensitizes ERα-negative breast cancer cells to TAM in vitro, we sought to determine whether FTY720 also enhances antiestrogen therapy in vivo. This evidence concerns the gene ESR1 and breast carcinoma.